Claim Missing Document
Check
Articles

Found 2 Documents
Search

The Relationship Between Acupressure Technique And The Reduction Of Nausea And Vomiting In Early Pregnancy Faizal Akbar Farid Musliem
The International Journal of Medical Science and Health Research Vol. 26 No. 2 (2026): The International Journal of Medical Science and Health Research
Publisher : International Medical Journal Corp. Ltd

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.70070/0yyhyn40

Abstract

Introduction: Nausea and vomiting in early pregnancy (NVP), commonly known as morning sickness, is a prevalent condition affecting a majority of pregnant women, significantly impacting their quality of life. While often managed with dietary adjustments or pharmacological interventions, there is a growing interest in safe, non-invasive, and non-pharmacological alternatives. Acupressure, a traditional Chinese medicine technique applying pressure to specific acupoints, has emerged as a potential intervention, with the P6 (Neiguan) point being the most commonly targeted. This systematic review synthesizes the current evidence on the effectiveness of acupressure techniques for reducing NVP. Methods: A systematic review methodology was employed. Electronic databases were searched for studies published up to 2025. Studies were screened based on pre-defined criteria focusing on pregnant women in the first trimester experiencing NVP, interventions using pressure-based acupressure techniques, and designs including randomized controlled trials (RCTs), quasi-experimental studies, and systematic reviews. Data were extracted on study design, population characteristics, intervention protocols (points, method, duration), outcome measures, and results. The findings from 71 included sources were synthesized narratively and quantitatively where appropriate. Results: The synthesis of evidence from 71 studies, including RCTs, quasi-experimental designs, and meta-analyses, indicates that acupressure is an effective intervention for reducing NVP. The P6 point was the most frequently studied and demonstrated significant efficacy. Meta-analyses reported strong pooled evidence; for instance, one found acupressure reduced nausea (RR=0.47) and vomiting (RR=0.59) significantly (R. Helmreich et al., 2006). Quasi-experimental studies showed substantial pre-post symptom reductions (e.g., B. Devi, 2020). Acupressure was found effective for mild to moderate NVP, with emerging evidence supporting its use even in hyperemesis gravidarum (HG), particularly as an adjunct (Nor Azila Mohd Nafiah et al., 2022; H. Shin & Young A Song, 2005). Combination therapies with ginger or aromatherapy often yielded enhanced effects (Nikmah Jalilah Ritonga et al., 2020; Risa Ayu Faturanti et al., 2025). The safety profile was consistently favorable with minimal adverse effects. Discussion: The evidence supports acupressure as a viable, safe, and effective non-pharmacological option for managing NVP. Effectiveness appears influenced by symptom severity, methodological rigor, intervention protocol (e.g., continuous vs. intermittent application), and comparator type. While placebo effects may contribute, especially in unblinded studies, the consistent positive findings across diverse study designs strengthen the case for its clinical utility. Acupressure offers a practical, self-administerable option that aligns with patient preferences for minimal intervention during pregnancy. Conclusion: Acupressure, particularly at the P6 point, is recommended as an effective first-line or adjunctive intervention for reducing nausea and vomiting in early pregnancy, especially for women with mild to moderate symptoms. It presents a favorable safety profile. Future research should focus on standardized protocols, long-term effects, and cost-effectiveness to facilitate integration into routine prenatal care.
A Comprehensive Systematic Review of The Relationship between Vitamin E Consumption and the Risk of Preeclampsia Faizal Akbar Farid Musliem
The Indonesian Journal of General Medicine Vol. 31 No. 1 (2026): The Indonesian Journal of General Medicine
Publisher : International Medical Journal Corp. Ltd

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.70070/pxp2vv33

Abstract

Background: Preeclampsia remains a leading cause of maternal and perinatal morbidity and mortality worldwide. Oxidative stress has been implicated in its pathogenesis, positioning vitamin E as a potential preventive agent due to its antioxidant properties. However, evidence regarding its efficacy remains conflicting. Methods: A comprehensive systematic review was conducted following PRISMA guidelines. We searched multiple databases for studies examining the relationship between vitamin E consumption and preeclampsia risk. Inclusion criteria encompassed randomized controlled trials, cohort studies, case-control studies, and cross-sectional studies involving pregnant women. Data extraction included study characteristics, vitamin E exposure details, preeclampsia outcomes, biochemical markers, and confounding variables. Forty-six studies met inclusion criteria, comprising 12 RCTs, 8 cohort studies, 15 case-control studies, 13 cross-sectional studies, and 2 reviews. Results: RCTs demonstrated heterogeneous findings. While one trial using tocotrienol-rich fraction showed 97% risk reduction (aOR 0.030, 95% CI: 0.001-0.65; Aminuddin et al., 2021), large trials found no benefit (Poston et al., 2006; Beazley et al., 2005). The largest cohort study (n=73,317) identified a threshold effect at 7.3 mg/L serum vitamin E, with levels <5.5 mg/L associated with 29.56-fold increased risk (Shi et al., 2022). Observational studies consistently demonstrated lower vitamin E levels in preeclamptic women (Chaudhary et al., 2022; Aamir et al., 2021; Nnamdi et al., 2021). Dietary intake studies showed low intake was associated with increased risk (Rumbold et al., 2005; Masrikhiyah et al., 2016), but supplementation >100 mg/day in replete women was associated with harm (OR 1.68; Yang et al., 2025). Biochemical studies confirmed elevated oxidative stress markers and reduced antioxidant capacity in preeclampsia (Omar et al., 2019; Suhail et al., 2008; Begum et al., 2012). Discussion: The apparent contradiction between RCTs and observational studies is reconciled by baseline vitamin E status. The threshold effect at 7.3 mg/L explains why supplementation benefits deficient populations but not replete populations. Form of vitamin E (tocotrienols vs. alpha-tocopherol) and dose considerations are critical. Conclusion: Routine vitamin E supplementation is not supported in well-nourished populations. Targeted supplementation in vitamin E-deficient women (serum <7.3 mg/L) warrants further investigation.